Carotid and Renal Artery Stents Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2023 Update
Carotid and Renal Artery Stents Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2023 Update
Summary
GlobalData's Medical Devices sector report, “Carotid and Renal Artery Stents Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2023 Update provides comprehensive information about the Carotid and Renal Artery Stents pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.
Carotid artery stents are expandable tubes that are implanted in narrowed carotid arteries to increase the flow of blood. Carotid arteries become narrowed due to plaque formation and buildup in the inner surface of the arteries.
Note:Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.
Scope
Extensive coverage of the Carotid and Renal Artery Stents under development
The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
The report reviews the major players involved in the development of Carotid and Renal Artery Stents and list all their pipeline projects
The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
The report provides key clinical trial data of ongoing trials specific to pipeline products
Recent developments in the segment / industry
Reasons to Buy
The report enables you to -
Formulate significant competitor information, analysis, and insights to improve R&D strategies
Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage
Identify and understand important and diverse types of Carotid and Renal Artery Stents under development
Develop market-entry and market expansion strategies
Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
In-depth analysis of the product’s current stage of development, territory and estimated launch date
About GlobalData
Introduction
Carotid and Renal Artery Stents Overview
Products under Development
Carotid and Renal Artery Stents - Pipeline Products by Stage of Development
Table Figure 1: Carotid and Renal Artery Stents - Pipeline Products by Stage of Development
Table Carotid and Renal Artery Stents - Pipeline Products by Stage of Development
Carotid and Renal Artery Stents - Pipeline Products by Segment
Table Figure 2: Carotid and Renal Artery Stents - Pipeline Products by Segment
Table Carotid and Renal Artery Stents - Pipeline Products by Segment
Carotid and Renal Artery Stents - Pipeline Products by Territory
Table Figure 3: Carotid and Renal Artery Stents - Pipeline Products by Territory
Table Carotid and Renal Artery Stents - Pipeline Products by Territory
Carotid and Renal Artery Stents - Pipeline Products by Regulatory Path
Table Figure 4: Carotid and Renal Artery Stents - Pipeline Products by Regulatory Path
Table Carotid and Renal Artery Stents - Pipeline Products by Regulatory Path
Carotid and Renal Artery Stents - Pipeline Products by Estimated Approval Date
Table Figure 5: Carotid and Renal Artery Stents - Pipeline Products by Estimated Approval Date
Table Carotid and Renal Artery Stents - Pipeline Products by Estimated Approval Date
Carotid and Renal Artery Stents - Ongoing Clinical Trials
Table Contego Medical LLC - Ongoing Clinical Trials Overview
Table Neuroguard IEP System - Protection Against Emboli During Carotid Artery Stenting Using a 3-in-1 Delivery System Comprised of a Post-dilation Balloon, Integrated Embolic Filter and a Novel Carotid Stent II
Table Neuroguard IEP System - Protection Against Emboli During caRotid Artery Stenting Using a Neuroguard IEP(R) Direct 3-in-1 Delivery System Comprised oF a pOst-dilation Balloon, integRated eMbolic Filter, and A Novel Carotid stEnt – the PERFORMANCE III Study
Table CGuard Embolic Prevention System - A Multicenter, Single-arm, Pivotal Study to Evaluate the Safety and Efficacy of the CGuard Carotid Stent System When Used to Treat Symptomatic and Asymptomatic Carotid Artery Stenosis in Patients Undergoing Carotid Artery Stenting
Table CGuard Embolic Prevention System - Acute Stroke of Carotid Artery Bifurcation Origin Treated with Use of the Micronet-covered CGUARD Stent Under Transient Flow Reversal Linked with Thrombus Retrieval: SAFEGUARD-STROKE Study
Table CGuard Embolic Prevention System - An Early Feasibility Study (EFS) Assessing the CGuard Embolic Prevention Carotid Stent to Treat Severe Carotid Stenosis or Occlusion
Table CGuard Embolic Prevention System - Long-term Outcomes of MicroNet-covered Stent Routine Use for Stroke Prevention in Symptomatic and Increased-risk Asymptomatic Carotid Stenosis Patients Requiring Revascularization by Neurovascular Team Decision: PARADIGM-EXTEND
Table CGuard Embolic Prevention System - OPTIMAl Endovascular Exclusion of High-risk Carotid Plaque Using the Cguard Stent in Patients with Symptoms or Signs of Carotid Stenosis-related Brain Injury: IVUS Controlled Investigator Initiated Multcentric Multi-specialty Study
Table CGuard Embolic Prevention System - Prospective Observational Study of CGuard MicroNet Covered Stent System Use as a Flow Diverter in the Endovascular Exclusion of Carotid Artery Aneurysms. (CGuard Divert-and-HEAL C-HEAL)
Carotid and Renal Artery Stents- Recent Developments
Nov 27, 2023: Inspiremd Announces Strategic Agreement with Jacobs Institute to Execute Early Feasibility Study of Cguard EPS for the Treatment of Acute Stroke Patients with Tandem Lesions
Nov 10, 2023: Microport Appointment of Director
Nov 01, 2023: Contego Medical Announces One-Year Outcomes From the Performance II Carotid Stent Trial
Nov 01, 2023: Third Round of Late-Breaking Clinical Trial Results Announced at VIVA23
Oct 26, 2023: Boston Scientific Announces Results for Third Quarter 2023
Oct 16, 2023: Cordis Issues Statement on the CMS Announcement to Expand Coverage of Carotid Stenting
Oct 09, 2023: Contego Medical enrols first patient in Neuroguard IEPsystem trial
Oct 04, 2023: Medtronic Names Paolo Di Vincenzo President of the Neuromodulation Business
Sep 29, 2023: Barry Slowey Named Vice President and Chief Sustainability Officer
Sep 15, 2023: Amber Beauchamp Named Vice President of Global Human Resources
Aug 31, 2023: InspireMD Announces Abstract of 30-Day Results from the C-Guardians U.S. Investigational Device Exemption (IDE) Clinical Trial Accepted for Presentation at VIVA23
Aug 26, 2023: Medtronic Q2 2024 Earnings Estimates Increased by William Blair
Aug 24, 2023: Endologix Announces that Lucas Buchanan Joins Board of Directors
Aug 11, 2023: W. L. Gore & Associates to Present New Mosa Paper At Gvsets Conference
Aug 08, 2023: Medtronic to Announce Financial Results for its First Quarter of Fiscal Year 2024
Jul 19, 2023: Boston Scientific lays off 52 workers as it closes another Silicon Valley facility
Jul 11, 2023: Microport Scientific Provides Consolidated Earnings Guidance for the Six Months Ended June 30, 2023
May 11, 2023: Medtronic to announce financial results for its fourth quarter and full fiscal year 2023
Apr 26, 2023: MicroPort announces annual results for 2022
Apr 12, 2023: Medtronic has a layoff in California
Mar 16, 2023: Medtronic joins in $25M funding round for home monitoring company
Feb 06, 2023: Surmodics Lays off 58 employees
Feb 06, 2023: Surmodics Reports First Quarter of Fiscal Year 2023 Financial Results; Updates Fiscal Year 2023 Financial Guidance
Jan 31, 2023: Surmodics to Host Virtual Annual Meeting of Shareholders